The 138 references without contexts in paper Editorial article , Редакционная статья (2016) “Хроническая обструктивная болезнь легких: профилактика обострений. Клинические рекомендации Американской коллегии торакальных врачей и Канадского торакального общества (часть 2-я) // Therapeutic strategy to prevent acute exacerbations of chronic obstructive pulmonary disease: clinical guidelines of American College of Chest Physicians and Canadian Thoracic Society Guideline (Part 2)” / spz:neicon:pulmonology:y:2016:i:3:p:267-291

1
Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management and pre" vention of chronic obstructive pulmonary disease. Updated 2103. Global Initiative for Chronic Obstructive Lung Disease website. http://www.goldcopd. org/uploads/ users/files/GOLD_Report_2013_Feb20.pdf.Accessed May 15, 2014.
(check this in PDF content)
2
Brusasco V. Reducing cholinergic constriction: the major reversible mechanism in COPD.Eur. Respir. Rev.2006; 15 (99): 32–36. Больные ХОБЛ (старше 40 лет, бывшие или активные курильщики; постбронходилатационный ОФВ1/ ФЖЕЛ < 0,70) Высокий риск обострений ХОБЛ (острое ухудшение с необходимостью назначения АБП и / или системных ГКС: при среднетяжелом – амбулаторно, при тяжелом – в стационаре) Рекомендуется: • ежегодная противогриппоз6 ная вакцинация • легочная реабилитация (обострение ≤4 нед.) • обучение и индивидуаль6 ное ведение при ежемесячном наблюдении Желательно: • пневмококковая вакцинация • отказ от курения • обучение с планом дейст6 вий и индивиду6 альным веде6 нием Нежелательно: • легочная реабилитация (обострение > 4 нед.) • обучение и индивидуаль ное ведени
(check this in PDF content)
3
Cooper C.B. Airflow obstruction and exercise. Respir. Med. 2009; 103 (3): 325–334.
(check this in PDF content)
4
Public Health Agency of Canada. Chronic obstructive pul" monary disease (COPD). Public Health Agency of Canada website. http://www.phac#aspc.gc.ca/cd#mc/crd#mrc/copd# mpoc#eng.php.Accessed June 28, 2012.
(check this in PDF content)
5
Centers for Disease Control and Prevention; National Center for Health Statistics. Deaths: final data for 2009. Natl. Vital. Stat. Rep. 2012; 60 (3): 1–117.
(check this in PDF content)
6
Centers for Disease Control and Prevention; National Center for Health Statistics. National Health Interview Survey Raw Data, 1999–2011. Analysis performed by the American Lung Association Research and Healtheducation Division using SPSS and SUDAAN software. Atlanta GA: Centers for Disease Control and Prevention; 2011.
(check this in PDF content)
7
Mannino D.M., Homa D.M., Akinbami L.J. et al. Centers for Disease Control and Prevention. Chronic obstructive pulmonary disease surveillance – United States, 1971– 2000. MMWR Surveill. Summ.2002; 51 (6): 1–16.
(check this in PDF content)
8
Centers for Disease Control and Prevention; National Center for Health Statistics. National Hospital Discharge Survey Raw Data, 1999–2010. Analysis Performed by the American Lung Association Research and Health" education Division Using SPSS Soft ware. Atlanta GA: Centers for Disease Control and Prevention; 2010.
(check this in PDF content)
9
Confronting COPD in America, 2000. Schulman, Ronca and Bucuvalas, Inc. (SRBI); 2000. Funded by Glaxo SmithKline plc.
(check this in PDF content)
10
Mittmann N., Kuramoto L., Seung S.J. et al. The cost of moderate and severe COPD exacerbations to the Canadian healthcare system. Respir. Med. 2008; 102 (3): 413–421.
(check this in PDF content)
11
Chapman K.R., Bourbeau J., Rance L. The burden of COPD in Canada: results from the Confronting COPD survey. Respir. Med.2003; 97 (Suppl. C): S23–S31.
(check this in PDF content)
12
Connors A.F. Jr, Dawson N.V., Thomas C. et al. Outcomes following acute exacerbation of severe chronic obstructive lung disease. The SUPPORT investigators (Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments). Am. J. Respir. Crit. Care Med. 1996; 154 (4): 959–967.
(check this in PDF content)
13
Seemungal T.A., Donaldson G.C., Paul E.A. et al. Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 1998; 157 (5): 1418–1422.
(check this in PDF content)
14
Miravitlles M., Murio C., Guerrero T. et al. Pharmaco" economic evaluation of acute exacerbations of chronic bronchitis and COPD. Chest. 2002; 121 (5): 1449–1455.
(check this in PDF content)
15
Miravitlles M., García"Polo C., Domenech A. et al. Cli" nical outcomes and cost analysis of exacerbations in chronic obstructive pulmonary disease. Lung. 2013; 191 (5): 523–530.
(check this in PDF content)
16
Wouters E.F. Economic analysis of the confronting COPD survey: an overview of results. Respir. Med. 2003; 97 (Suppl. C): S3–S14.
(check this in PDF content)
19
Rodriguez"Roisin R. Toward a consensus definition for COPD exacerbations. Chest. 2000; 117 (5, Suppl. 2): 398S–401S.
(check this in PDF content)
20
Qaseem A., Wilt T.J., Weinberger S.E. et al. Diagnosis and management of stable chronic obstructive pulmonary dis" ease: a clinical practice guideline update from the American College of Physicians, American College of Chest Physicians, American Thoracic Society, and Euro" pean Respiratory Society. Ann. Intern. Med. 2011; 155 (3): 179–191.
(check this in PDF content)
24
Lewis S.Z., Diekemper R., Ornelas J., Casey K.R. Methodologies for the development of CHEST guidelines and expert panel reports. Chest. 2014; 146 (1): 182–192.
(check this in PDF content)
25
Brouwers M.C., Kho M.E., Browman G.P. et al. AGREE II: advancing guideline development, reporting and evalua" tion in health care. CMAJ. 2010; 182 (18): E839–E842.
(check this in PDF content)
26
Diekemper R., Ireland B., Merz L. P154 development of the Documentation and Appraisal Review Tool (DART) for systematic reviews [poster]. Br. Med. J. Qual. Saf.2013; 22: 61–62.
(check this in PDF content)
27
Higgins J.P.T., Altman D.G., Sterne J.A.C. et al. Chapter 8: assessing risk of bias in included studies. In: Higgins J.P.T., Green S, eds. Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 [updated March 2011]. London:The Cochrane Collaboration; 2011.
(check this in PDF content)
28
Downs S.H., Black N. The feasibility of creating a check" list for the assessment of the methodological quality both of randomised and non"randomised studies of health care interventions.J. Epidemiol. Community Health.1998; 52 (6): 377–384.
(check this in PDF content)
29
Langer"Gould A., Popat R.A., Huang S.M. et al. Clinical and demographic predictors of long"term disability in patients with relapsing"remitting multiple sclerosis: a sys" tematic review. Arch. Neurol. 2006; 63 (12): 1686–1691.
(check this in PDF content)
30
Aaron S.D., Fergusson D., Marks G.B. et al. Counting, analysing and reporting exacerbations of COPD in ran" domised controlled trials. Thorax. 2008; 63 (2): 122–128.
(check this in PDF content)
31
Balshem H., Helfand M., Schünemann H.J. et al. GRADE guidelines: 3. Rating the quality of evidence. J. Clin. Epidemiol.2011; 64 (4): 401–406.
(check this in PDF content)
32
Guyatt G., Gutterman D., Baumann M.H. et al. Grading strength of recommendations and quality of evidence in clinical guidelines: report from an American College of Chest Physicians task force. Chest. 2006; 129 (1): 174–181.
(check this in PDF content)
33
Graham I.D., Logan J., Harrison M.B. et al. Lost in knowledge translation: time for a map? J. Contin. Educ. Health Prof. 2006; 26 (1): 13–24.
(check this in PDF content)
34
Bodenheimer T., Wagner E.H., Grumbach K. Improving primary care for patients with chronic illness. JAMA. 2002; 288 (14): 1775–1779.
(check this in PDF content)
35
Bodenheimer T., Wagner E.H., Grumbach K. Improving primary care for patients with chronic illness: the chronic care model, part 2. JAMA. 2002; 288 (15): 1909–1914.
(check this in PDF content)
36
Chronic obstructive pulmonary disease: management of chronic obstructive pulmonary disease in adults in primary and secondary care (partial update). National Institute for Хроническая обструктивная болезнь легких: профилактика обострений. Клинические рекомендации CHEST / CTS 284 Health and Care Excellence website. http://guidance.nice. org.uk/CG101/Guidance/pdf/English.Accessed May 15, 2014.
(check this in PDF content)
37
O’Donnell D.E., Aaron S., Bourbeau J. et al. Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease"2007 update. Can. Respir. J.2007; 14 (Suppl. B): 5B–32B.
(check this in PDF content)
38
Disler R.T., Inglis S.C., Davidson P.M. Non"pharmaco" logical management interventions for COPD: an overview of Cochrane systematic reviews (protocol). Cochrane Database Syst. Rev.2013; (2): CD010384.
(check this in PDF content)
39
Kruis A.L., Smidt N., Assendelft W.J.J. et al. Integrated disease management interventions for patients with chron" ic obstructive pulmonary disease. Cochrane Database Syst. Rev.2011; (10): CD009437.
(check this in PDF content)
40
Krumholz H.M., Currie P.M., Riegel B. et al. A taxonomy for disease management: a scientific statement from the American Heart Association Disease Management Taxonomy Writing Group. Circulation. 2006; 114 (13): 1432–1445.
(check this in PDF content)
41
Craig P., Dieppe P., Macintyre S. et al. Research Council Guidance. Developing and evaluating complex interven" tions: the new Medical Research Council guidance. Br. Mer. J. 2008; 337: a1655.
(check this in PDF content)
42
Petticrew M. When are complex interventions ‘complex’? When are simple interventions ‘simple’? Eur. J. Public. Health.2011; 21 (4): 397–398.
(check this in PDF content)
43
Weightman A., Ellis S., Cullum A. et al. Grading Evidence and Recommendations for Public Health Interventions: Developing and Piloting a Framework. London: Health Development Agency; 2005.
(check this in PDF content)
44
Vaccines and immunizations. Centers for Disease Control and Prevention website. http://www.cdc.gov/vaccines/vpd# vac/pneumo. Accessed March 3, 2014.
(check this in PDF content)
45
Lee T.A., Weaver F.M., Weiss K.B. Impact of pneumococ" cal vaccination on pneumonia rates in patients with COPD and asthma. J. Gen. Intern. Med.2007; 22 (1): 62–67.
(check this in PDF content)
46
Centers for Disease Control and Prevention; Advisory Committee on Immunization Practices. Updated recom" mendations for prevention of invasive pneumococcal dis" ease among adults using 23"valent pneumococcal polysac" charide vaccine (PPSV23). Morb. Mortal. Wkly Rep. 2010; 59 (34): 1102–1106.
(check this in PDF content)
47
Bogaert D., van der Valk P., Ramdin R. et al. Host" pathogen interaction during pneumococcal infection in patients with chronic obstructive pulmonary disease. Infect. Immun. 2004; 72 (2): 818–823.
(check this in PDF content)
48
Patel I.S., Seemungal T.A.R., Wilks M. et al. Relationship between bacterial colonisation and the frequency, charac" ter, and severity of COPD exacerbations. Thorax. 2002; 57 (9): 759–764.
(check this in PDF content)
49
Sethi S., Evans N., Grant B.J.B., Murphy T.F. New strains of bacteria and exacerbations of chronic obstructive pul" monary disease.N. Engl. J. Med.2002; 347 (7): 465–471.
(check this in PDF content)
50
Papi A., Bellettato C.M., Braccioni F. et al. Infections and airway inflammation in chronic obstructive pulmonary disease severe exacerbations. Am. J. Respir. Crit. Care Med. 2006; 173 (10): 1114–1121.
(check this in PDF content)
51
WHO recommendations for routine immunization sum" mary tables. World Health Organization website. http:// www.who.int/immunization/policy/immunization_tables/en. Accessed March 3, 2014.
(check this in PDF content)
52
Walters J.A., Smith S., Poole P. et al. Injectable vaccines for preventing pneumococcal infection in patients with chronic obstructive pulmonary disease. Cochrane Database Syst. Rev.2010; (11): CD001390.
(check this in PDF content)
53
Dransfield M.T., Harnden S., Burton R.L. al. Long"term comparative immunogenicity of protein conjugate and free polysaccharide pneumococcal vaccines in chronic obstructive pulmonary disease. Clin. Infect. Dis.2012; 55 (5): e35–e44.
(check this in PDF content)
54
Furumoto A., Ohkusa Y., Chen M. et al. Additive effect of pneumococcal vaccine and influenza vaccine on acute exacerbation in patients with chronic lung disease. Vaccine. 2008; 26 (33): 4284–4289.
(check this in PDF content)
55
Fiore A.E., Uyeki T.M., Broder K. et al. Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010. MMWR Rec. Rep.2010; 59 (RR"8): 1–62.
(check this in PDF content)
56
Centanni S., Pregliasco F., Bonfatti C. et al. Clinical effi" cacy of a vaccine"immunostimulant combination in the prevention of influenza in patients with chronic obstruc" tive pulmonary disease and chronic asthma. J. Chemother. 1997; 9 (4): 273–278.
(check this in PDF content)
57
Monto A.S. Influenza: quantifying morbidity and mortal" ity. Am. J. Med.1987; 82 (6A): 20–25.
(check this in PDF content)
58
Poole P., Chacko E.E., Wood"Baker R., Cates C.J. Influenza vaccine for patients with chronic obstructive pulmonary disease. Cochrane Database Syst. Rev.2006; (1): CD002733.
(check this in PDF content)
59
Howells C.H., Tyler L.E. Prophylactic use of influenza vaccine in patients with chronic bronchitis. A pilot trial. Lancet. 1961; 278 (7218): 1428–1432.
(check this in PDF content)
60
Wongsurakiat P., Maranetra K.N., Wasi C. et al. Acute res" piratory illness in patients with COPD and the effective" ness of influenza vaccination: a randomized controlled study. Chest. 2004; 125 (6): 2011–2020.
(check this in PDF content)
61
Fletcher C., Peto R. The natural history of chronic airflow obstruction. Br. Med. J.1977; 1 (6077): 1645–1648.
(check this in PDF content)
62
Hersh C.P., DeMeo D.L., Al"Ansari E. et al. Predictors of survival in severe, early onset COPD. Chest. 2004; 126 (5): 1443–1451.
(check this in PDF content)
63
Scanlon P.D., Connett J.E., Waller L.A. et al. Smoking cessation and lung function in mild"to"moderate chronic obstructive pulmonary disease. The Lung Health Study. Am. J. Respir. Crit. Care Med. 2000; 161 (2): 381–390.
(check this in PDF content)
64
Kanner R.E., Connett J.E., Williams D.E., Buist A.S. Effects of randomized assignment to a smoking cessation intervention and changes in smoking habits on respiratory symptoms in smokers with early chronic obstructive pul" monary disease: the Lung Health Study. Am. J. Med. 1999; 106 (4): 410–416.
(check this in PDF content)
65
Makris D., Moschandreas J., Damianaki A. et al. Exacer" bations and lung function decline in COPD: new insights in current and ex"smokers. Respir. Med. 2007; 101 (6): 1305–1312.
(check this in PDF content)
66
Tashkin D., Kanner R., Bailey W. et al. Smoking cessation in patients with chronic obstructive pulmonary disease: a double"blind, placebo"controlled, randomised trial. Lancet. 2001; 357 (9268): 1571–1575.
(check this in PDF content)
67
Jiménez"Ruiz C.A., Masa F., Miravitlles M. et al. Smoking characteristics: diff erences in attitudes and dependence between healthy smokers and smokers with COPD. Chest. 2001; 119 (5): 1365–1370.
(check this in PDF content)
68
Strassmann R., Bausch B., Spaar A. et al. Smoking cessa" tion interventions in COPD: a network metaanalysis of randomised trials. Eur. Respir. J.2009; 34 (3): 634–640.
(check this in PDF content)
69
Meer R.M., Wagena E.J., Ostelo R.W. et al. Smoking cessation for chronic obstructive pulmonary dis" ease.Cochrane Database Syst. Rev. 2003; (2): CD002999.
(check this in PDF content)
70
Tønnesen P., Carrozzi L., Fagerström K.O. et al. Smoking cessation in patients with respiratory diseases: a high prior" ity, integral component of therapy.Eur. Respir. J. 2007; 29 (2): 390–417.
(check this in PDF content)
71
Au D.H., Bryson C.L., Chien J.W. et al. The effects of smoking cessation on the risk of chronic obstructive pul" monary disease exacerbations. J. Gen. Intern. Med. 2009; 24 (4): 457–463.
(check this in PDF content)
72
Christenhusz L.C., Prenger R., Pieterse M.E. et al. Cost" effectiveness of an intensive smoking cessation interven" tion for COPD outpatients. Nicotine Tob. Res.2012; 14 (6): 657–663.
(check this in PDF content)
73
Borglykke A., Pisinger C., Jørgensen T., Ibsen H. The effectiveness of smoking cessation groups offered to hospi" talised patients with symptoms of exacerbations of chron" ic obstructive pulmonary disease (COPD). Clin. Respir. J. 2008; 2 (3): 158–165.
(check this in PDF content)
74
Godtfredsen N.S., Vestbo J., Osler M., Prescott E. Risk of hospital admission for COPD following smoking cessation and reduction: a Danish population study. Thorax. 2002; 57 (11): 967–972.
(check this in PDF content)
75
Szabo E., Mao J.T., Lam S. et al. Chemoprevention of lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence" based clinical practice guidelines. Chest. 2013; 143 (5, Suppl.): e40S–e60S.
(check this in PDF content)
76
Spruit M.A., Singh S.J., Garvey C. et al; ATS/ERS Task Force on Pulmonary Rehabilitation. An official American Thoracic Society / European Respiratory Society state" ment: key concepts and advances in pulmonary rehabilita" tion. Am. J. Respir. Crit. Care Med. 2013; 188 (8): e13–e64.
(check this in PDF content)
77
Marciniuk D.D., Brooks D., Butcher S. et al. Optimizing pulmonary rehabilitation in chronic obstructive pul" monary disease – practical issues: a Canadian Thoracic Society Clinical Practice Guideline. Can. Respir. J. 2010; 17 (4): 159–168.
(check this in PDF content)
78
Ries A.L., Bauldoff G.S., Carlin B.W. et al. Pulmonary rehabilitation: Joint ACCP/AACVPR evidence"based clinical practice guidelines. Chest. 2007; 131 (5, Suppl.): 4S–42S.
(check this in PDF content)
79
Lacasse Y., Goldstein R., Lasserson T.J., Martin S. Pulmo" nary rehabilitation for chronic obstructive pulmonary dis" ease. Cochrane Database Syst. Rev. 2006; (4): CD003793.
(check this in PDF content)
80
Lacasse Y., Wong E., Guyatt G.H. et al. Meta"analysis of respiratory rehabilitation in chronic obstructive pul" monary disease. Lancet. 1996; 348 (9035): 1115–1119.
(check this in PDF content)
81
Nici L., ZuWallack R. An official American Thoracic Society workshop report: the integrated care of the COPD patient.Proc. Am. Thorac. Soc. 2012; 9 (1): 9–18.
(check this in PDF content)
82
Ko F.W., Dai D.L., Ngai J. et al. Effect of early pulmonary rehabilitation on health care utilization and health status in patients hospitalized with acute exacerbations of COPD. Respirology. 2011; 16 (4): 617–624.
(check this in PDF content)
83
Behnke M., Taube C., Kirsten D. et al. Home"based exer" cise is capable of preserving hospital"based improvements in severe chronic obstructive pulmonary disease. Respir. Med. 2000; 94 (12): 1184–1191.
(check this in PDF content)
84
Murphy N., Bell C., Costello R.W. Extending a home from hospital care programme for COPD exacerbations to include pulmonary rehabilitation. Respir. Med. 2005; 99 (10): 1297–1302.
(check this in PDF content)
85
Ringbaek T., Brondum E., Martinez G. et al. Long"term effects of 1"year maintenance training on physical func" tioning and health status in patients with COPD: a ran" domized controlled study. J. Cardiopulm. Rehabil. Prev. 2010; 30 (1): 47–52.
(check this in PDF content)
86
Román M., Larraz C., Gómez A. et al. Efficacy of pul" monary rehabilitation in patients with moderate chronic obstructive pulmonary disease: a randomized controlled trial. BMC Fam. Pract. 2013; 14: 21.
(check this in PDF content)
87
Man W.D., Polkey M.I., Donaldson N. et al. Community pulmonary rehabilitation after hospitalisation for acute exacerbations of chronic obstructive pulmonary disease: randomised controlled study. Br. Med. J. 2004; 329 (7476): 1209.
(check this in PDF content)
88
Seymour J.M., Moore L., Jolley C.J. et al. Outpatient pul" monary rehabilitation following acute exacerbations of COPD. Thorax. 2010; 65 (5): 423–428.
(check this in PDF content)
89
Boxall A.M., Barclay L., Sayers A., Caplan G.A. Managing chronic obstructive pulmonary disease in the community. A randomized controlled trial of home"based pulmonary rehabilitation for elderly housebound patients. J. Cardiopulm. Rehabil. 2005; 25 (6): 378–385.
(check this in PDF content)
90
Eaton T., Young P., Fergusson W. et al. Does early pulmo" nary rehabilitation reduce acute health"care utilization in COPD patients admitted with an exacerbation? A random" ized controlled study. Respirology. 2009; 14 (2): 230–238.
(check this in PDF content)
91
Puhan M.A., Gimeno"Santos E., Scharplatz M. et al. Pulmonary rehabilitation following exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst. Rev.2011; (10): CD005305.
(check this in PDF content)
92
Wagner E.H. Chronic disease management: what will it take to improve care for chronic illness? Eff. Clin. Pract. 1998; 1 (1): 2–4.
(check this in PDF content)
93
Case Management Society of America. What is a case manager? Case Management Society of America website. http://www.cmsa.org/Home/CMSA/WhatisaCaseManager/ tabid/224/Default.aspx. Accessed March 18, 2014.
(check this in PDF content)
94
Zwerink M., Brusse"Keizer M., van der Valk P.D. et al. Self management for patients with chronic obstructive pul" monary disease.Cochrane Database Syst. Rev. 2014; (3): CD002990.
(check this in PDF content)
95
Jarab A.S., Alqudah S.G., Khdour M. et al. Impact of pharmaceutical care on health outcomes in patients with COPD. Int. J. Clin. Pharmacol. 2012; 34 (1): 53–62.
(check this in PDF content)
96
Farrero E., Escarrabill J., Prats E. et al. Impact of a hospi" tal"based home"care program on the management of COPD patients receiving long"term oxygen therapy. Chest. 2001; 119 (2): 364–369.
(check this in PDF content)
97
Lainscak M., Kadivec S., Kosnik M. et al. Discharge coor" dinator intervention prevents hospitalizations in patients with COPD: a randomized controlled trial. J. Am. Med. Dir. Assoc. 2013; 14 (6): 450.e1–450.e6.
(check this in PDF content)
98
Smith B.J., Appleton S.L., Bennett P.W. et al. The effect of a respiratory home nurse intervention in patients with chronic obstructive pulmonary disease (COPD). Aust. N. Z. J. Med.1999; 29 (5): 718–725.
(check this in PDF content)
99
Soler J.J., Martínez"García M.A., Román P. et al. Effectiveness of a specific program for patients with chronic obstructive pulmonary disease and frequent exacerbations. Arch. Bronconeumol.2006; 42 (10): 501–508 (in Spanish).
(check this in PDF content)
100
Gallefoss F. The effects of patient education in COPD in a 1"year follow"up randomised, controlled trial. Patient Educ. Couns.2004; 52 (3): 259–266.
(check this in PDF content)
101
McGeoch G.R., Willsman K.J., Dowson C.A. et al. Self" management plans in the primary care of patients with chronic obstructive pulmonary disease. Respirology. 2006; 11 (5): 611–618.
(check this in PDF content)
102
Wakabayashi R., Motegi T., Yamada K. et al. Efficient integrated education for older patients with chronic Хроническая обструктивная болезнь легких: профилактика обострений. Клинические рекомендации CHEST / CTS 286 obstructive pulmonary disease using the Lung Information Needs Questionnaire.Geriatr. Gerontol. Int.2011; 11 (4): 422–430.
(check this in PDF content)
103
Wood"Baker R., McGlone S., Venn A., Walters E.H. Written action plans in chronic obstructive pulmonary dis" ease increase appropriate treatment for acute exacerba" tions. Respirology. 2006; 11 (5): 619–626.
(check this in PDF content)
104
Bourbeau J., Julien M., Maltais F. et al. Chronic Obstructive Pulmonary Disease axis of the Respiratory Network Fonds de la Recherche en Santédu Québec. Reduction of hospital utilization in patients with chronic obstructive pulmonary disease: a diseasespecific self"man" agement intervention. Arch. Intern. Med. 2003; 163 (5): 585–591.
(check this in PDF content)
105
Casas A., Troosters T., Garcia"Aymerich J. et al. Integ" rated care prevents hospitalisations for exacerbations in COPD patients. Eur. Respir. J. 2006; 28 (1): 123–130.
(check this in PDF content)
106
Fan V.S., Gaziano J.M., Lew R. et al. A comprehensive care management program to prevent chronic obstructive pulmonary disease hospitalizations: a randomized, con" trolled trial.Ann. Intern. Med. 2012; 156 (10): 673–683.
(check this in PDF content)
107
Khdour M.R., Kidney J.C., Smyth B.M., McElnay J.C. Clinical pharmacy"led disease and medicine management programme for patients with COPD. Br. J. Clin. Pharma# col. 2009; 68 (4): 588–598.
(check this in PDF content)
108
Rea H., McAuley S., Stewart A. et al. A chronic disease management programme can reduce days in hospital for patients with chronic obstructive pulmonary disease. Intern. Med. J. 2004; 34 (11): 608–614.
(check this in PDF content)
109
Rice K.L., Dewan N., Bloomfield H.E. et al. Disease management program for chronic obstructive pulmonary disease: a randomized controlled trial.Am. J. Respir. Crit. Care Med.2010; 182 (7): 890–896.
(check this in PDF content)
110
Trappenburg J.C., Monninkhof E.M., Bourbeau J. et al. Effect of an action plan with ongoing support by a case manager on exacerbation"related outcome in patients with COPD: a multicenter randomised controlled trial. Thorax. 2011; 66 (11): 977–984.
(check this in PDF content)
111
Walters J., Cameron"Tucker H., Wills K. et al. Effects of telephone health mentoring in community"recruited chronic obstructive pulmonary disease on self"manage" ment capacity, quality of life and psychological morbidity: a randomised controlled trial. Br. Med. J. Open.2013; 3 (9): e003097.
(check this in PDF content)
112
Bischoff E.W., Akkermans R., Bourbeau J. et al. Compre" hensive self management and routine monitoring in chronic obstructive pulmonary disease patients in general practice: randomised controlled trial. Br. Med. J. 2012; 345: e7642.
(check this in PDF content)
113
Coultas D., Frederick J., Barnett B. et al. A randomized trial of two types of nurse"assisted home care for patients with COPD. Chest. 2005; 128 (4): 2017–2024.
(check this in PDF content)
114
Gadoury M.A., Schwartzman K., Rouleau M. et al; Chronic Obstructive Pulmonary Disease axis of the Respiratory Health Network, Fonds de la recherche en Santédu Québec (FRSQ). Self"management reduces both short" and long"term hospitalisation in COPD.Eur. Respir. J. 2005; 26 (5): 853–857.
(check this in PDF content)
115
Hermiz O., Comino E., Marks G. et al. Randomised con" trolled trial of home based care of patients with chronic obstructive pulmonary disease. Br. Med. J. 2002; 325 (7370): 938.
(check this in PDF content)
116
Telemedicine: opportunities and developments in member states. Report on the second global survey on eHealth. World Health Organization website. http://www.who.int/ goe/ publications/goe_telemedicine_2010.pdf.Accessed March 13, 2014.
(check this in PDF content)
117
What is telemedicine? American Telemedicine Association website. http://www.americantelemed.org/about#telemedicine/ what#is#telemedicine.Accessed March 13, 2014.
(check this in PDF content)
118
Toledo P., Jiménez S., del Pozo F. et al. Telemedicine experience for chronic care in COPD. IEEE Trans. Inf. Technol. Biomed. 2006; 10 (3): 567–573.
(check this in PDF content)
119
Vitacca M., Bianchi L., Guerra A. et al. Tele"assistance in chronic respiratory failure patients: a randomised clinical trial. Eur. Respir. J. 2009; 33 (2): 411–418.
(check this in PDF content)
120
Wong K.W., Wong F.K., Chan M.F. Effects of nurse"initi" ated telephone follow"up on self"efficacy among patients with chronic obstructive pulmonary disease. J. Adv. Nurs. 2005; 49 (2): 210–222.
(check this in PDF content)
121
McLean S., Nurmatov U., Liu J.L. et al. Telehealthcare for chronic obstructive pulmonary disease. Cochrane Database Syst. Rev. 2011; (7): CD007718.
(check this in PDF content)
122
Antoniades N.C., Rochford P.D., Pretto J.J. et al. Pilot study of remote telemonitoring in COPD. Telemed. J. E. Health. 2012; 18 (8): 634–640.
(check this in PDF content)
123
Chau J.P., Lee D.T., Yu D.S. et al. A feasibility study to investigate the acceptability and potential effectiveness of a telecare service for older people with chronic obstructive pulmonary disease. Int. J. Med. Inform. 2012; 81 (10): 674–682.
(check this in PDF content)
124
Dinesen B., Haesum L.K., Soerensen N. et al. Using pre" ventive home monitoring to reduce hospital admission rates and reduce costs: a case study of telehealth among chronic obstructive pulmonary disease patients.J. Tele# med. Telecare.2012; 18 (4): 221–225.
(check this in PDF content)
125
Gellis Z.D., Kenaley B., McGinty J. et al. Outcomes of a telehealth intervention for homebound older adults with heart or chronic respiratory failure: a randomized con" trolled trial. Gerontologist. 2012; 52 (4): 541–552.
(check this in PDF content)
126
Haesum L.K., Soerensen N., Dinesen B. et al. Cost"utili" ty analysis of a telerehabilitation program: a case study of COPD patients.Telemed. J. E. Health.2012; 18 (9): 688–692.
(check this in PDF content)
127
Halpin D.M., Laing"Morton T., Spedding S. et al. A ran" domized controlled trial of the effect of automated inter" active calling combined with a health risk forecast on fre" quency and severity of exacerbations of COPD assessed clinically and using EXACT PRO. Prim. Care Respir. J. 2011; 20 (3): 324–331.
(check this in PDF content)
128
Henderson C., Knapp M., Fernández J.L. et al. Cost effectiveness of telehealth for patients with long term con" ditions (Whole Systems Demonstrator telehealth ques" tionnaire study): nested economic evaluation in a prag" matic, cluster randomised controlled trial. Br. Med. J. 2013; 346: f1035.
(check this in PDF content)
129
Holland A. Telehealth reduces hospital admission rates in patients with COPD.J. Physiother.2013; 59 (2): 129.
(check this in PDF content)
130
Jódar"Sánchez F., Ortega F., Parra C. et al. Imple" mentation of a telehealth programme for patients with severe chronic obstructive pulmonary disease treated with long"term oxygen therapy.J. Telemed. Telecare.2013; 19 (1): 11–17.
(check this in PDF content)
131
Koff P.B., Jones R.H., Cashman J.M. et al. Proactive inte" grated care improves quality of life in patients with COPD. Eur. Respir. J. 2009; 33 (5): 1031–1038.
(check this in PDF content)
132
Lewis K.E., Annandale J.A., Warm D.L. et al. Does home telemonitoring after pulmonary rehabilitation reduce healthcare use in optimized COPD? A pilot randomized trial. COPD. 2010; 7 (1): 44–50.
(check this in PDF content)
133
ParéG., Poba"Nzaou P., Sicotte C. et al. Comparing the costs of home telemonitoring and usual care of chronic obstructive pulmonary disease patients: a randomized con" trolled trial. Eur. Res. Telemed.2013; 2 (2): 35–47.
(check this in PDF content)
134
Pedone C., Chiurco D., Scarlata S., Incalzi R.A. Efficacy of multiparametric telemonitoring on respiratory out" comes in elderly people with COPD: a randomized con" trolled trial. BMC Health Serv. Res. 2013; 13: 82.
(check this in PDF content)
135
Pinnock H., Hanley J., Lewis S. et al. The impact of a telemetric chronic obstructive pulmonary disease moni" toring service: randomised controlled trial with economic evaluation and nested qualitative study. Prim. Care Respir. J. 2009; 18 (3): 233–235.
(check this in PDF content)
136
Shany T., Hession M., Pryce D. et al. Home telecare study for patients with chronic lung disease in the Sydney West Area Health Service. Stud. Health Technol. Inform. 2010; 161: 139–148.
(check this in PDF content)
138
Steventon A., Bardsley M., Billings J. et al. Effect of tele" health on use of secondary care and mortality: findings from the Whole System Demonstrator cluster randomised trial.Br. Med. J.2012; 344: e3874.
(check this in PDF content)
139
Venter A., Burns R., Hefford M., Ehrenberg N. Results of a telehealth"enabled chronic care management service to support people with long"term conditions at home. J. Telemed. Telecare.2012; 18 (3): 172–175.
(check this in PDF content)
244
Decramer M., Rutten"van Mölken M., Dekhuijzen P.N. et al. Effects of N"acetylcysteine on outcomes in chronic obstructive pulmonary disease (Bronchitis Randomized on NAC Cost"Utility Study, BRONCUS): a randomised placebo"controlled trial. Lancet. 2005; 365 (9470): 1552–1560.
(check this in PDF content)
245
Dueholm M., Nielsen C., Thorshauge H. et al. N"acetyl" cysteine by metered dose inhaler in the treatment of chronic bronchitis: a multi"centre study. Respir. Med. 1992; 86 (2): 89–92.
(check this in PDF content)
246
Parr G.D., Huitson A. Oral Fabrol (oral N"acetyl"cys" teine) in chronic bronchitis. Br. J. Dis. Chest.1987; 81 (4): 341–348.
(check this in PDF content)
247
Rasmussen J.B., Glennow C. Reduction in days of illness aft erlongterm treatment with N"acetylcysteine con" trolled"release tablets in patients with chronic bronchitis. Eur. Respir. J. 1988; 1 (4): 351–355.
(check this in PDF content)
248
Schermer T., Chavannes N., Dekhuijzen R. et al. Flu" ticasone and N"acetylcysteine in primary care patients with COPD or chronic bronchitis. Respir. Med. 2009; 103 (4): 542–551.
(check this in PDF content)